bio chat
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
“Innovate in India is
anticipated as the game
changer for biopharma
industry”
In an exclusive interaction with the BioVoice News, the Managing
Director of UBM India , Mr Yogesh Mudras shared his thoughts on
the present scenario and future of pharma sector. Read the
interesting interview below
BY RAHUL KOUL
How do you look at
the growth of the
Indian bio-pharma
sector in terms of
size and scale over
decades? What are
the opportunities
that still remain
untapped?
industry and has
contributed towards
making life-saving
drugs and low cost
pharmaceutical
products accessible
and affordable. Be it
the Rotavirus vaccine,
heart valve prosthesis
or affordable insulin.
However, despite these
India is playing an
active role in the global developments, the
biopharmaceutical
pharmaceutical
40
BioVoiceNews | Dec 2017 - Jan 2018
industry of India is
lagging when
compared with the
developed countries
and is facing tough
competition from other
countries. Recently in
this year in June, the
Government of India
launched a program
Innovate in India (i3)
for the Indian
biopharmaceutical